A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.
Huge challenges face healthcare professionals and policy makers in planning for, and providing cancer care over the next decade or so. Chief amongst these will be ensuring that healthcare professionals have the skills and knowledge to treat a greater number of elderly people with cancer, that current inappropriate ageist attitudes towards the elderly cease, and that advances are made in ensuring that cancer patients are able to comply with their treatment.
Recent political decisions have had serious consequences for European oncology, said Professor John Smyth at ECCO 14, the European Cancer Conference, today.
Implementation of the Physical Agents (Electromagnetic Fields) Directive 2004/40/EC in all Member States could effectively halt the use of magnetic resonance imaging (MRI), an important tool in cancer diagnosis, treatment, and research, a scientist told a press conference at the European Cancer Conference (ECCO 14) today (Monday September 24). The Directive is due to be implemented across Europe by April 2008.
The Indian Department of Science & Technology has proposed to bring in a new legislation to enforce uniform and effective standards of Medical Devices throughout the country.
Anti-cancer treatments often effectively shrink the size of tumors, but some might have an opposite effect, actually expanding the small population of cancer stem cells believed to drive the disease, according to findings presented Sept. 19 by Vasyl Vasko, M.D. Ph.D., a pathologist at the Uniformed Services University of the Health Sciences (USU) at the American Association for Cancer Research’s second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
National Cervical Cancer Coalition unites women in joining the fight for education and early detection and prevention of the Human Papillomavirus (HPV) and cervical cancer. National Cervical Cancer Coalition conducted two days conference at the Hyatt Regency Capitol Hill in the heart of Washington, D.C.
National Cervical Cancer Coalition unites women in joining the fight for education and early detection and prevention of the Human Papillomavirus (HPV) and cervical cancer.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Pharmaceutical company GenVec’s malaria vaccine candidate is well-tolerated and induces an immune response, according to results from a Phase I/II clinical trial presented by the company at the Malaria Vaccines for the World Conference at the Royal Society of Medicine in London.